-----BEGIN PRIVACY-ENHANCED MESSAGE----- Proc-Type: 2001,MIC-CLEAR Originator-Name: webmaster@www.sec.gov Originator-Key-Asymmetric: MFgwCgYEVQgBAQICAf8DSgAwRwJAW2sNKK9AVtBzYZmr6aGjlWyK3XmZv3dTINen TWSM7vrzLADbmYQaionwg5sDW3P6oaM5D3tdezXMm7z1T+B+twIDAQAB MIC-Info: RSA-MD5,RSA, PCifxP2L5OpVx6Bh0Sv0SKu0gEjxTytvLycdzMYS7sued/W287KWZWYGkYME6ZVd ZfwBIOjXm07SNXAqGnHE/A== 0001231977-05-000031.txt : 20050907 0001231977-05-000031.hdr.sgml : 20050907 20050907113359 ACCESSION NUMBER: 0001231977-05-000031 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20050902 FILED AS OF DATE: 20050907 DATE AS OF CHANGE: 20050907 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: ALEXION PHARMACEUTICALS INC CENTRAL INDEX KEY: 0000899866 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 133648318 STATE OF INCORPORATION: DE FISCAL YEAR END: 0731 BUSINESS ADDRESS: STREET 1: 352 KNOTTER DRIVE CITY: CHESHIRE STATE: CT ZIP: 06511 BUSINESS PHONE: 2037761790 MAIL ADDRESS: STREET 1: 352 KNOTTER DRIVE CITY: CHESHIRE STATE: CT ZIP: 06511 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: KEISER DAVID W CENTRAL INDEX KEY: 0001231953 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 000-27756 FILM NUMBER: 051072055 MAIL ADDRESS: STREET 1: C/O ALEXION PHARMACEUTICALS INC STREET 2: 352 KNOTTER DRIVE CITY: CHESHIRE STATE: CT ZIP: 06410 4 1 primary_doc.xml PRIMARY DOCUMENT X0202 4 2005-09-02 0 0000899866 ALEXION PHARMACEUTICALS INC ALXN 0001231953 KEISER DAVID W C/O ALEXION PHARMACEUTICALS INC 352 KNOTTER DRIVE CHESHIRE CT 06410 1 1 0 0 President & COO Common Stock, par value $.0001 2005-09-02 4 F 0 7500 28.57 D 62000 D Common Stock, par value $.0001 2005-09-02 4 M 0 21427 10 A 83427 D Option to Purchase Common Stock, par value $.0001 10 2005-09-02 4 M 0 21427 0 D 1999-05-17 2006-05-17 Common Stock, par value $.0001 21427 5568 D As indicated, the 21,427 shares acquired upon exercise of incentive stock options and the exercise price was paid by surrendering 7,500 shares of common stock then owned by the reporting person to the issuer. The sales reported by this Form 4 are made pursuant to the terms of a Sales Plan designed to meet the requirements of Rule 10b5-1 (c) (1) of the Securities Exchange Act. /s/ David W. Keiser 2005-09-07 -----END PRIVACY-ENHANCED MESSAGE-----